The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
NCT05156138 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-12-14
Summary
The study aims to compare the endothelial cell count in patients with pseudoexfoliation syndrome to the the endothelial cell count in normal patients above the age of 50.
Conditions
- Pseudoexfoliation Syndrome
Interventions
- OTHER
-
no interventions as it is a case control observational study
no interventions as it is a case control observational study
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-24
- Primary Completion
- 2022-07-24
- Completion
- 2022-09-24
Countries
- Egypt
Study Locations
More Related Trials
-
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
NCT02339441 ·Status: COMPLETED
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Penn SICCA Follow-up Study
NCT05056012 ·Status: NOT_YET_RECRUITING
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN
-
IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy
NCT07235813 ·Status: COMPLETED ·Phase: NA
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease
NCT02896205 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Echo Systemic Sclerosis
NCT03143413 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
NCT00442611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Calcinosis Reduction by Pyrophosphate in SSC
NCT04966416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
NCT05157958 ·Status: RECRUITING ·Phase: PHASE2
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
Cytokines in Papillon-Lefèvre Syndrome
NCT01116934 ·Status: COMPLETED
-
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
NCT02834520 ·Status: COMPLETED
-
Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma
NCT00070590 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Photobiomodulation in the Treatment of Hand-foot Syndrome
NCT05337423 ·Status: TERMINATED ·Phase: NA
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED